Tumor markers (CEA and CA 19.9), as well as inflammatory markers—leukocytes, neutrophils, neutrophil/lymphocyte (N/L) index, platelets, fibrinogen, C-reactive protein (CRP), and interleukin 6 (IL6)— were also analyzed. This evidence concerns the gene CRP and neoplasm.